UA60352C2 - Синтетичні полісахариди та фармацевтична композиція, що їх містить - Google Patents

Синтетичні полісахариди та фармацевтична композиція, що їх містить

Info

Publication number
UA60352C2
UA60352C2 UA2000074011A UA00074011A UA60352C2 UA 60352 C2 UA60352 C2 UA 60352C2 UA 2000074011 A UA2000074011 A UA 2000074011A UA 00074011 A UA00074011 A UA 00074011A UA 60352 C2 UA60352 C2 UA 60352C2
Authority
UA
Ukraine
Prior art keywords
preparing
pharmaceutical composition
composition containing
synthetic polysaccharides
polysaccharides
Prior art date
Application number
UA2000074011A
Other languages
English (en)
Russian (ru)
Inventor
Йоханнес БАСТЕН
Корнеліа Дреф-Тромп
Пьєр-Александр Дрігез
Філіпп Дюшосуа
Жан-Марк Ербер
Жан-Марк Эрбер
Моріс Петіту
БУККЕЛ Констант ВАН
Original Assignee
Санофі-Сентелябо
Санофи-Сентелябо
Акзо Нобель Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофі-Сентелябо, Санофи-Сентелябо, Акзо Нобель Н.В. filed Critical Санофі-Сентелябо
Publication of UA60352C2 publication Critical patent/UA60352C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Згідно з винаходом запропоновано синтетичні полісахариди у кислотній формі та їх фармацевтично прийнятні солі, аніонні форми яких відповідають одній з описаних у формулі винаходу формул (I)-(V). Вказані полісахариди можна використовувати для лікування асоційованих з дисфункцією коагуляції розладах.
UA2000074011A 1998-01-19 1999-01-13 Синтетичні полісахариди та фармацевтична композиція, що їх містить UA60352C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800515A FR2773804B1 (fr) 1998-01-19 1998-01-19 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
PCT/FR1999/000044 WO1999036443A1 (fr) 1998-01-19 1999-01-13 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Publications (1)

Publication Number Publication Date
UA60352C2 true UA60352C2 (uk) 2003-10-15

Family

ID=9521914

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000074011A UA60352C2 (uk) 1998-01-19 1999-01-13 Синтетичні полісахариди та фармацевтична композиція, що їх містить

Country Status (41)

Country Link
US (1) US6528497B1 (uk)
EP (1) EP1049721B1 (uk)
JP (1) JP4402835B2 (uk)
KR (1) KR100513196B1 (uk)
CN (1) CN1165550C (uk)
AR (1) AR013019A1 (uk)
AT (1) ATE209219T1 (uk)
AU (1) AU741748B2 (uk)
BR (1) BRPI9907025B8 (uk)
CA (1) CA2317465C (uk)
CO (1) CO4970795A1 (uk)
CZ (1) CZ297815B6 (uk)
DE (1) DE69900718T2 (uk)
DK (1) DK1049721T3 (uk)
DZ (1) DZ2709A1 (uk)
EE (1) EE04157B1 (uk)
EG (1) EG23982A (uk)
ES (1) ES2168000T3 (uk)
FR (1) FR2773804B1 (uk)
GT (1) GT199900003A (uk)
HK (1) HK1030002A1 (uk)
HR (1) HRP20000480B1 (uk)
HU (1) HU228333B1 (uk)
IL (1) IL137241A0 (uk)
MA (1) MA26597A1 (uk)
MY (1) MY119090A (uk)
NO (1) NO329903B1 (uk)
NZ (1) NZ505492A (uk)
PE (1) PE20000269A1 (uk)
PL (1) PL202802B1 (uk)
PT (1) PT1049721E (uk)
RU (1) RU2211224C2 (uk)
SA (1) SA99191113B1 (uk)
SI (1) SI1049721T1 (uk)
SK (1) SK283411B6 (uk)
TR (1) TR200002078T2 (uk)
TW (1) TW548279B (uk)
UA (1) UA60352C2 (uk)
UY (1) UY25356A1 (uk)
WO (1) WO1999036443A1 (uk)
ZA (1) ZA99355B (uk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
IL188647A0 (en) 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
WO2009130704A1 (en) * 2008-04-24 2009-10-29 Technion Research And Development Foundation Ltd. Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
KR101529061B1 (ko) 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
WO2010117803A2 (en) * 2009-03-30 2010-10-14 University Of Georgia Research Foundation, Inc. Heparan sulfate synthesis
EP2451442A4 (en) 2009-07-09 2014-02-12 Oshadi Drug Administration Ltd MATRIX COMPOSITION COMPOSITIONS, METHODS AND USES
US8288515B2 (en) 2009-07-31 2012-10-16 Reliable Biopharmaceutical Corporation Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2614089A1 (fr) 2010-09-10 2013-07-17 Sanofi-Aventis Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
US9005664B2 (en) 2010-10-17 2015-04-14 Technion Research And Development Foundation Ltd. Denatured lactoglobulin and polyphenol coassemblies
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
CZ427499A3 (cs) * 1998-05-29 2000-05-17 The Procter & Gamble Company Jemné topické antimikrobiální přípravky

Also Published As

Publication number Publication date
DZ2709A1 (fr) 2003-09-01
ES2168000T3 (es) 2002-05-16
BR9907025B1 (pt) 2013-12-10
NZ505492A (en) 2001-12-21
DE69900718T2 (de) 2002-08-22
FR2773804A1 (fr) 1999-07-23
CN1288470A (zh) 2001-03-21
ATE209219T1 (de) 2001-12-15
ZA99355B (en) 2000-10-11
DK1049721T3 (da) 2002-04-02
TR200002078T2 (tr) 2000-11-21
EE200000429A1 (et) 2003-06-16
PL341875A1 (en) 2001-05-07
CZ20002635A3 (cs) 2000-12-13
EE04157B1 (et) 2003-10-15
SA99191113B1 (ar) 2006-10-11
AR013019A1 (es) 2000-11-22
BR9907025A (pt) 2000-10-17
NO20003662D0 (no) 2000-07-17
PL202802B1 (pl) 2009-07-31
EP1049721B1 (fr) 2001-11-21
CZ297815B6 (cs) 2007-04-04
EP1049721A1 (fr) 2000-11-08
HK1030002A1 (en) 2001-04-20
HRP20000480A2 (en) 2000-12-31
CA2317465C (en) 2008-05-20
NO20003662L (no) 2000-09-14
AU1974599A (en) 1999-08-02
PT1049721E (pt) 2002-05-31
US6528497B1 (en) 2003-03-04
TW548279B (en) 2003-08-21
EE200000429A (et) 2001-12-17
KR20010034189A (ko) 2001-04-25
IL137241A0 (en) 2001-07-24
SI1049721T1 (en) 2002-06-30
EG23982A (en) 2008-02-27
RU2211224C2 (ru) 2003-08-27
WO1999036443A1 (fr) 1999-07-22
UY25356A1 (es) 2000-10-31
NO329903B1 (no) 2011-01-24
PE20000269A1 (es) 2000-06-15
CA2317465A1 (en) 1999-07-22
GT199900003A (es) 2000-07-07
CO4970795A1 (es) 2000-11-07
DE69900718D1 (de) 2002-02-21
FR2773804B1 (fr) 2000-02-18
KR100513196B1 (ko) 2005-09-07
HRP20000480B1 (en) 2002-04-30
HU228333B1 (en) 2013-03-28
JP4402835B2 (ja) 2010-01-20
MA26597A1 (fr) 2004-12-20
SK10782000A3 (sk) 2001-02-12
SK283411B6 (sk) 2003-07-01
CN1165550C (zh) 2004-09-08
MY119090A (en) 2005-03-31
HUP0102009A3 (en) 2003-07-28
AU741748B2 (en) 2001-12-06
JP2002509164A (ja) 2002-03-26
BRPI9907025B8 (pt) 2016-09-13
HUP0102009A1 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
UA60352C2 (uk) Синтетичні полісахариди та фармацевтична композиція, що їх містить
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
ATE398618T1 (de) Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL94267A0 (en) Compositions for treating skin disorders containing ketoconazole and their preparation
HUT61196A (en) Process for producing pharmaceutical composition which may be dropped in the eye
EP0793660A4 (en) 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
BG105275A (en) Tan-1057 derivatives
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
ATE259223T1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
UA37211C2 (uk) Похідні 1,4-дигідропіридину у формі рацемату або енантіомерів, 2-хлор-3-ціанобензальдегід як проміжний продукт для їх одержання та фармацевтична композиція, що має антагоністичну активність по відношенню до катіонів кальцію
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS